Navigation Links
Dow AgroSciences Delivering Beyond Expectations
Date:2/10/2009

strengthening its corn, cotton, sunflower, and canola product portfolio.

As a technology-driven company, Dow AgroSciences continues to rapidly advance game-changing biotechnology solutions such as SmartStax(TM), the industry's first eight-gene stack of traits in corn. He reported robust trait introgression work is underway to accelerate launch and ramp-up plans. The Dual Effective Dose provided by SmartStax will drive value in improving yield opportunities.

The Dow Herbicide Tolerance (DHT) family of traits is also advancing quickly in the company's pipeline. This technology will allow growers to use an additional herbicide over the top of key crops such as corn and soybeans, thus providing a more complete solution for growers as they look to enhance the performance of glyphosate.

The final example of delivering beyond expectations focused on the company's EXZACT(TM) Precision Technology. EXZACT Technology, which utilizes zinc finger proteins, provides the ability to do gene targeting, a long-standing but elusive goal of the biotechnology industry. The company is rapidly deploying and enhancing the technology in its research efforts and in collaboration with other industry partners.

Presentation slides are available on The Dow Chemical Company's Investor Presentations web site.

About Dow AgroSciences

Dow AgroSciences LLC, based in Indianapolis, Indiana, USA, is a top-tier agricultural company that combines the power of science and technology with the "Human Element" to constantly improve what is essential to human progress. Dow AgroSciences provides innovative technologies for crop protection, pest and vegetation management, seeds, traits, and agricultural biotechnology to serve the world's growing population. Global sales for Dow AgroSciences
'/>"/>

SOURCE The Dow Chemical Company
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Dow AgroSciences Receives Approval for Cultivation of HERCULEX(R) I Corn in Brazil
2. Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants
3. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration
4. Dow AgroSciences, Martek Biosciences Form Alliance to Bring Omega-3 Fatty Acids to Food Industry
5. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration
6. Dow AgroSciences Success Presented to Wall Street
7. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
8. OmniComm Systems, Inc. Is Fueled by Another Strong Quarter Delivering Electronic Data Capture (EDC) Solutions & Services
9. PARI Respiratory to Present New Study Comparing Nebulizers Delivering Budesonide at CHEST 2008
10. Medco CEO to Shareholders: Delivering Results, Driving Shareholder Value
11. Delivering Molecular Imaging Solutions Across Clinical Specialties: Siemens Showcases New Technologies at RSNA 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...ecently announced that Dr. Dominique Hebrault will...s Analytical Technology (PAT) in Green Chemistry a..., (PRWEB) November 20, 200...chnology (PAT) in Green Chemistry and Green Engine...echnology (PAT) case studies will be presented on ...
(Date:11/19/2009)...rstCall/ -- Omeros Corporation (Nasdaq: OMER ) to...third quarter ended September 30, 2009. For the th...ed a net loss of $3.9 million, or $1.34 per share,...54 per share, for the same period in 2008. For the... reported a net loss of $15.5 million, or $5.29 pe...
(Date:11/19/2009)...irstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), ann... to its shareholders, discussing the Company,s acq...euticals Holdings, Inc. (CHBP), an integrated bio-...lic of China. The merger gives NeoStem a controlli...Ltd., CHBP,s primary operating subsidiary and a pr...
(Date:11/19/2009)...er 19 MONITORING FORCE GmbH,announ...ibanserin in the,indication treatment-relevant lev...r orphan drug status designation with the European...sia is a complication of the mainstay,treatment in... of those,affected, since it may be disabling for ...
Breaking Biology Technology:Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2
... 16 ,Boston Scientific Corporation (NYSE: BSX ) a...the signing of a definitive merger agreement, unde... price of $1.35 per share of,CryoCor, or approxima...elopment agreement, in place since June 2007, to p...n, or "Afib." Afib is the most common,cardiac arrh...
... Inc.,announced today that it has closed the secon...cing. As previously announced, Aisling Capital led...ew investors, the D.E. Shaw,group and Boston Life ...omura Phase4 Ventures, Novartis BioVentures, BioFu... Hentsch, BioVeda Fund and Hercules,Technology Gro...
... Oncolytics Biotech Inc.,("Oncolytics") (TSX:ONC, ...er and his research group at St. James,s Universit...their work in the April 10 online issue of,Gene Th...Cell Killing by,Oncolytic Reovirus for the Treatme...eovirus effectively kills and replicates,in both h...
Other Biology Technology:Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement 2Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement 3Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement 4Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement 5Boston Scientific and CryoCor Announce Signing of Definitive Merger Agreement 6Paratek Pharmaceuticals Completes $40 Million Private Placement to Finance Clinical Programs Including Oral Antibiotic to Combat MRSA and Other Infections 2Paratek Pharmaceuticals Completes $40 Million Private Placement to Finance Clinical Programs Including Oral Antibiotic to Combat MRSA and Other Infections 3Oncolytics Biotech Inc. Announces Gene Therapy Publication on Reovirus Treatment for Melanoma 2
(Date:11/23/2009)...niversity of Alabama at Birmingham (UAB) researche...g medical conditions (co-morbidity) do not explain...ricans compared to Caucasians who also have colon ...Cancer , a journal of the American Cancer Society....o-morbidity are independent predictors of poor sur...
(Date:11/23/2009)...l in unprecedented detail how the ribosome interac...nd guide them toward their destination in biologic...ible fitting (MDFF) to examine the interaction of .... , The first study, in Proceedings of the Nat...signaling between the ribosome and an elongation f...
(Date:11/23/2009)...scoveries about the multiple health benefits of vi... nutrient, increased awareness of the huge numbers...ch and even led to an appreciation of it as "natur...alth of your immune system to prevention of heart ...in D is now seen as one of the most critical nutri...
Breaking Biology News(10 mins):Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3Multiple health concerns surface as winter, vitamin D deficiences arrive 2Multiple health concerns surface as winter, vitamin D deficiences arrive 3Helix BioPharma to Present L DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 12711 1Helix BioPharma to Present L DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 12711 2Helix BioPharma to Present L DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 12711 3Helix BioPharma to Present L DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 12711 4Helix BioPharma to Present L DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 12711 5Chemicals in Marijuana Smoke May Harm DNA 49526 1Synutra Annual Report on Form 10 K Includes Going Concern Explanatory Paragraph from Auditor 49524 1Synutra Annual Report on Form 10 K Includes Going Concern Explanatory Paragraph from Auditor 49524 2
... expanding into new territory, successfully aiding...valves in patients too sick to withstand open-ches...th Annual Scientific Sessions of the Society for C..., May 9?2, 2007, in Orlando, FL, patients who were...Valve, Irvine, CA) experienced improvements in bot...
...e use of tissue-engineered scaffolding made of car... naturally, to replace defective cartilage tissue....caffold which is implanted into the body, where ne...he study appears in the journal Artificial Organs....d mice as the study found these scaffolds to be a ...
...e-dose anticlotting medication just before percuta...d risk of heart attack and cardiac death by half, ...cientific Sessions of the Society for Cardiovascul...2007, in Orlando, FL. , Researchers found that gi...e stenting, rather than the standard 300-mg dose, ...
Other Biology News:Percutaneous aortic valve replacement safe, successful in high-risk patients 2High-dose anticlotting drug cuts heart attack, death risk in half 2
...RS are multi-functional mixing devices. Stepping m... solid, heavy-duty durable shaker to provide a uni...ature. Regulated action scale for all modes. Micro...trol time, continuous time, action scale and speed...
Finnigan LTQ FT from Thermo Scientific
PDQuest 10-User Network License from Bio-Rad
Mouse Anti-Human JRKL Monoclonal Antibody, Unconjugated, Clone 4E10 from Abnova Corporation
Biology Products: